Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Clarity Pharmaceuticals Ltd, explained in plain language.
This study tests a new type of PET scan that uses a radioactive tracer (64Cu-SAR-bisPSMA) to find prostate cancer that has come back after initial treatment. About 220 men with rising PSA levels will receive the tracer and be scanned. The goal is to see how well this scan detects…
Phase: PHASE3 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Diagnosis
Last updated May 17, 2026 01:59 UTC